Human IgG antibody Laboratories manufactures the lee biosolutions matt lee reagents distributed by Genprice. The Lee Biosolutions Matt Lee reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Lee Biosolutions Ltd.. Other Lee products are available in stock. Specificity: Lee Category: Biosolutions Group: Matt Lee
Matt Lee information
LEE011 succinate |
B1084-100 |
ApexBio |
100 mg |
EUR 420 |
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. |
LEE011 succinate |
B1084-200 |
ApexBio |
200 mg |
EUR 640.8 |
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. |
LEE011 succinate |
B1084-5 |
ApexBio |
5 mg |
EUR 160.8 |
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. |
LEE011 succinate |
B1084-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 192 |
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. |
LEE011 succinate |
B1084-50 |
ApexBio |
50 mg |
EUR 300 |
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. |
LEE011 succinate |
B1084-500 |
ApexBio |
500 mg |
EUR 1101.6 |
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. |
Ribociclib (LEE011) |
9481-25 |
Biovision |
each |
EUR 548.4 |
Ribociclib (LEE011) |
9481-5 |
Biovision |
each |
EUR 183.6 |
LEE011 hydrochloride |
B1083-10 |
ApexBio |
10 mg |
EUR 234 |
Description: LEE011 Hcl is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. |
LEE011 hydrochloride |
B1083-100 |
ApexBio |
100 mg |
EUR 602.4 |
Description: LEE011 Hcl is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. |
LEE011 hydrochloride |
B1083-5 |
ApexBio |
5 mg |
EUR 189.6 |
Description: LEE011 Hcl is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. |
LEE011 hydrochloride |
B1083-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 201.6 |
Description: LEE011 Hcl is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. |
LEE011 hydrochloride |
B1083-50 |
ApexBio |
50 mg |
EUR 385.2 |
Description: LEE011 Hcl is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. |
Recombinant Saccharomyces Cerevisiae LEE1 Protein (aa 1-301) [His] |
VAng-Wyb4934-1mg |
Creative Biolabs |
1 mg |
EUR 5289.6 |
Description: Saccharomyces Cerevisiae (strain ATCC 204508 / S288c) Lee1p protein, recombinant protein. |
[Des-Asp10]Decorsin, Leech |
5-00164 |
CHI Scientific |
4 x 1mg |
Ask for price |